ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 650599 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 650599; 2) Community: the network communities that were significantly associated with the response to NSC 650599; 3) Molecule: the relationships between components within communities and NSC 650599; 4) MDR: the compounds that were significantly associated with the NSC 650599.

NSC Compound Enrichment Correlation
NSC 710264 Null 0.0177048892222174 0.49477305
NSC 717147 Null 0.0177048892222174 -0.33560934
NSC 727049 11-(6'-Aminohexylidene]-5,6-dihydro-5-keto-2,3-dimethoxy-6-m ethyl-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinoline 0.0177048892222174 0.54075754
NSC 746087 1-(7-Fluoro-3-methyl-quinoxalin-2-yl)-3-(3,4,5-trimethoxy-phenyl)-propenone 0.0177048892222174 0.48064032
NSC 749 Azaguanine 0.0177048892222174 0.27857594
NSC 749296 2-methoxy-5H-pyrido[3,2:4,5]pyrrolo[3,2-c]cinnoline 0.0177048892222174 0.69937557
NSC 83142 Daunorubicin hydrochloride 0.0177048892222174 0.35906055
NSC 331935 CHALCONE ANALOG 0.0193573267900279 0.58786845
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0193573267900279 0.57243184
NSC 625502 Antimony, chlorobis(4-morpholinecarbodithioato-S,S')-, 0.0193573267900279 0.53523429
Total:116  Current:56    [First] [Prev] [Next] [Last]